Bio-Reference Labs - Comparative Multiple Analysis

Bio-Reference Labs (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of Bio-Reference Labs

WikiWealth compares Bio-Reference Labs's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Bio-Reference Labs's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Bio-Reference Labs.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Bio-Reference Labs's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Bio-Reference Labs's Analysis

How does this work? The Comparative Investment Analysis determines the value of Bio-Reference Labs by comparing Bio-Reference Labs financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Bio-Reference Labs.

See the Bio-Reference Labs cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Bio-Reference Labs.

Also, see the Bio-Reference Labs's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Bio-Reference Labs's valuation conclusion for a quick summary.